EUCTR2007-006595-11-GB进行中(未招募)1 期
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF).
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Age 18- 42 (upon starting COH);
- •BMI <30 kg/m2;
- •<3 prior ART cycles (IVF, ICSI and related procedures);
- •Baseline (day 2-3 of cycling) FSH <15 IU/L and E2 <80 pg/mL;
- •Normal uterine cavity as per recent hysterosalpingogram, sonohystogram or hysteroscopic exam (i.e. no polyp or protruding sub-mucosal fibroid);
- •At least 3 retrieved oocytes;
- •Patient has given written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Intramural uterine fibroids that distort the uterine cavity or polyps >1 cm;
- •-Stage III or IV endometriosis (endometriomas);
- •-Hydrosalpinx;
- •-History of past poor response to COH resulting in canceling ART;
- •-Use of thawed/donated oocytes;
- •-Use of thawed/donated embryos;
- •-Patients affected by pathologies associated with any contraindication of being pregnant;
- •-Hypersensitivity to study medication;
- •-Uncontrolled adrenal or thyroid dysfunction;
- •-Undiagnosed vaginal bleeding;
- •-History of arterial disease;
- •-Patients with hepatic impairment;
- •-Neoplasias (current) or history of neoplasia that may be responsive to progesterone;
- •-High grade cervical dysplasia;
研究者
相似试验
进行中(未招募)
不适用
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF).uteal phase support in patients undergoing Assisted Reproductive Technology (IVF).MedDRA version: 14.1Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2007-006595-11-ITIBSA672
进行中(未招募)
不适用
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA)versus Vaginal Progesterone Gel (Crinone®) for Luteal Phase Supportin Patients Undergoing In-Vitro Fertilization (IVF).Patient undergoing in-Vitro Fertlization (IVF)MedDRA version: 9.1Level: LLTClassification code 10021572Term: In vitro fertilizationEUCTR2007-006595-11-HUIBSA Institute Biochimique SA672
进行中(未招募)
不适用
Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) versus Vaginal Progesterone Gel (Crinone?) for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF).Patient undergoing in-Vitro Fertilization (IVF)MedDRA version: 9.1Level: LLTClassification code 10021572Term: In vitro fertilizationEUCTR2007-006595-11-DEIBSA Institut Biochimique SA672
招募中
Unknown
Evaluation of Efficacy and Safety of subcutaneous Remsima injection in Subjetcs with Active Ankylosing SpondylitisDiseases of the musculoskeletal system and connective tissueKCT0008747CHONNAM NATIONAL UNIVERSITY BITGOEUL HOSPITA60
尚未招募
2 期
ESAR-814 StudyRheumatoid arthritis with moderate activityArthritis, RheumatoidArthritisJoint DiseasesRheumatic DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesRPCEC00000230Center for Genetic Engineering and Biotechnology (CIGB), in Havana196
